Advanced search
Publication Cover
International Journal of General Medicine Volume 13, 2020 - Issue
Submit an article Journal homepage
104
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Cardiovascular System Affection and Its Relation to First-Year Mortality in Patients Initiating Maintenance Hemodialysis

Omaima Mohamed Ali1 Internal Medicine Department, Faculty of Medicine, Aswan University, Aswan, EgyptCorrespondence[email protected]
,
Aml Ahmed Sayed1 Internal Medicine Department, Faculty of Medicine, Aswan University, Aswan, EgyptORCID Iconhttps://orcid.org/0000-0002-2246-8742
ORCID Icon,
Wafaa Salah Mohammed2 Clinical Pathology Department, Faculty of Medicine, Aswan University, Aswan, Egypt
&
Ragaa Ramadan Mohammed3 Internal Medicine Department, Faculty of Medicine, Al-Azhar University for Girls, Cairo, Egypt
Pages 379-385 | Published online: 09 Jul 2020

References

  • Hill NR, Fatoba ST, Oke JL, et al. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.015876527383068
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2014;63(5):713–735. doi:10.1053/j.ajkd.2014.01.41624647050
  • Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100. doi:10.1111/j.1523-1755.2005.00365.x15882252
  • Abbasi MA, Chertow GM, Hall YN. End-stage renal disease. BMJ Clin Evid. 2010;2010.
  • Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int. 2005;68:S11–S17. doi:10.1111/j.1523-1755.2005.09802.x
  • Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;95:997–999. doi:10.1056/NEJMp058318
  • El-Ballat MA, El-Sayed MA, Emam HK. Epidemiology of end stage renal disease patients on regular hemodialysis in El-Beheira governorate, Egypt. Egypt J Hosp Med. 2019;76(3):3618–3625.
  • Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–2047. doi:10.1681/ASN.200510108516738019
  • Eiam-Ong S, Sitprija V. Comorbidities in patients with end-stage renal disease in developing countries. Artif Organ. 2002;26(9):753–756. doi:10.1046/j.1525-1594.2002.07064.x
  • Perneger TV, Klag MJ, Whelton PK. Cause of death in patients with end-stage renal disease: death certificates vs registry reports. Am J Public Health. 1993;83(12):1735–1738. doi:10.2105/AJPH.83.12.17358259805
  • Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85–97. doi:10.1161/CIRCULATIONAHA.106.67834217606856
  • Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31(6):703–711. doi:10.1093/eurheartj/ehp50720037146
  • Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28–iii34. doi:10.1093/ndt/gfy17430281132
  • Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F. The cardiovascular burden in end-stage renal disease. Contrib Nephrol. 2017;191:44–57.28910790
  • Noordzij M, Jager KJ. Increased mortality early after dialysis initiation: a universal phenomenon. Kidney Int. 2014;85(1):12–14. doi:10.1038/ki.2013.31624380902
  • Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13(3):745–753.11856780
  • Moradi H, Sica DA, Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol. 2013;38(2):136–148. doi:10.1159/00035175823941724
  • Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol. 2003;14(2):415–424. doi:10.1097/01.ASN.0000043140.23422.4F12538742
  • Tong J, Liu M, Li H, et al. Mortality and associated risk factors in dialysis patients with cardiovascular disease. Kidney Blood Press Res. 2016;41(4):479–487. doi:10.1159/00044344927434642
  • Bloembergen WE, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol. 1994;5(5):1231–1242.7873734
  • Wang AY-M, Lam CW-K, Chan IH-S, Wang M, Lui S-F, Sanderson JE. Sudden cardiac death in end-stage renal disease patients. Hypertension. 2010;56(2):210–216. doi:10.1161/HYPERTENSIONAHA.110.15116720606110
  • Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone,and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305:1119–1127. doi:10.1001/jama.2011.30821406649
  • Kawaguchi T, Tong L, Robinson BM, et al. C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract. 2011;117(2):c167–c178. doi:10.1159/00032011620714167
  • Endre ZH, Walker RJ. Biomarkers of cardiovascular risk in chronic kidney disease. Biomarkers Kid Dis. 2016.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.